logo
episode-header-image
Apr 2021
11m 15s

The U.S. Vaccination Rate Continues To S...

NPR
About this episode
Short Wave's Emily Kwong talks with NPR health correspondent Allison Aubrey about some of the latest coronavirus news, including the return of the Johnson & Johnson vaccine in the U.S. and vaccine outreach in harder to reach communities.

Have questions about the latest coronavirus headlines? Email us at shortwave@npr.org and we might cover it on a future episode.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy
Up next
Today
Why The Tropics Have A Weather Forecasting Problem
Weather in the tropics is decidedly different than it is in the middle latitudes. It turns out, so are the weather systems – the factors that create things like the daily temperature and humidity! Historically, most weather forecasting models have been based on data from high-inc ... Show More
14m 7s
Oct 8
Doing Science at the Edge of the Earth
Some scientific discoveries take place in a lab. Others are made deep in the rainforest, along the ocean floor or on the dark side of the moon. And still others are made squelching through mud and ice on the northernmost island on Earth… at least, if you’re NPR climate correspond ... Show More
13m 15s
Oct 7
Solved: The Potato Origin Mystery
Usually, when two different species mate, it’s a disaster. At least, that’s what scientists had generally thought about hybrids, the offspring of these unions. But some researchers are starting to change their view as they learn of more beneficial hybrid events. The Atlantic scie ... Show More
12m 27s
Recommended Episodes
Feb 2021
Third Vaccine On The Way, Fauci Hails 'Spectacular Results'
A third COVID-19 vaccine could receive emergency use authorization from the Food and Drug Administration this month. The vaccine made by Johnson & Johnson is 66% effective in preventing moderate to severe disease, according to a global study. Combined with the two vaccines curren ... Show More
12m 29s
Jan 2021
Why U.S. Vaccinations Started Slow And What We Know About The New Coronavirus Variant
Initially, U.S. officials predicted that as many as 20 million Americans would be fully vaccinated before the end of 2020. And while that many vaccine doses were distributed, only a fraction of them have been administered. The federal government has given states control over dist ... Show More
12m 21s
Jan 2021
Why Are U.S. Coronavirus Cases Falling? And Will the Trend Last?
The number of new coronavirus cases in the United States is falling, but has the country turned a corner in the pandemic? And what kind of threats do the new variants pose to people and to the vaccine rollout?Today, we discuss the latest in the quest to stamp out the pandemic.  G ... Show More
26m 17s
Nov 2020
A Vaccine Breakthrough
It’s a dark time in the struggle with the coronavirus, particularly in the United States, where infections and hospitalizations have surged.But amid the gloom comes some light: A trial by the drug maker Pfizer has returned preliminary results suggesting that its vaccine is 90 per ... Show More
24m 29s
Mar 2021
The State of Vaccinations
The United States has never undertaken a vaccination campaign of the scale and speed of the Covid-19 program. Despite a few glitches, the country appears to be on track to offer shots to all adults who want one by May 1.We look at the ups and downs in the American vaccination cam ... Show More
26m 42s
Dec 2020
Vaccine hesitancy, the next pandemic hurdle
As the Pfizer-BioNTech vaccine rolls out across the country, and other vaccines await imminent regulatory approval, many public health experts are focusing on the issue of vaccine hesitancy. Canada's Chief Public Health Officer Dr. Theresa Tam has spoken out about the "moveable m ... Show More
31m 47s
Sep 2020
Why Are So Many Americans Hesitant To Get A COVID-19 Vaccine?
As trials continue for a coronavirus vaccine, some of the world's biggest drug companies have come together in an unusual way. This week, nine drugmakers released a joint statement pledging to not submit a coronavirus vaccine to the Food and Drug Administration unless it's shown ... Show More
12m 50s
Apr 2020
The Race for a Vaccine
Scientists are racing to make a vaccine for the coronavirus, collaborating across borders in what is usually a secretive and competitive field. But their cooperation has been complicated by national leaders trying to buy first claim on any breakthrough. Today, we explore how the ... Show More
24m 32s
Dec 2020
Race for the Vaccine
On the same day the COVID-19 death toll surpassed 300,000 in the United States, the first vaccines are being administered, finally giving millions of Americans hope for a better future and a return to normalcy. We explore how officials expect to deliver a safe and effective vacci ... Show More
39m 42s